Jane N Winter

Jane N Winter

UNVERIFIED PROFILE

Are you Jane N Winter?   Register this Author

Register author
Jane N Winter

Jane N Winter

Publications by authors named "Jane N Winter"

Are you Jane N Winter?   Register this Author

100Publications

3626Reads

32Profile Views

Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status.

Leuk Lymphoma 2019 12 21;60(13):3266-3271. Epub 2019 Jun 21.

Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1622099DOI Listing
December 2019

Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma.

Int J Radiat Oncol Biol Phys 2019 06 11;104(2):436-446. Epub 2019 Feb 11.

Department of Radiation Oncology, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.02.007DOI Listing
June 2019

Controversies in the Approach to Initial Therapy of Hodgkin Lymphoma.

Curr Oncol Rep 2019 03 27;21(5):39. Epub 2019 Mar 27.

Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-019-0788-0DOI Listing
March 2019

Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma.

J Clin Oncol 2018 10 4;36(30):3015-3022. Epub 2018 Sep 4.

Andrew M. Evens, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Ranjana H. Advani, Stanford University, Stanford, CA; Irene B. Helenowski, Borko D. Jovanovic, Jane N. Winter, and Leo I. Gordon, Northwestern University Feinberg School of Medicine; Jane N. Winter and Leo I. Gordon, Robert H. Lurie Comprehensive Cancer Center; Sonali M. Smith, University of Chicago, Chicago, IL; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Gregory R. Bociek, University of Nebraska, Omaha, NE; Andreas K. Klein, Tufts Medical Center, Boston, MA; and Paul A. Hamlin, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.0139DOI Listing
October 2018

The impact of fertility preservation on treatment delay and progression-free survival in women with lymphoma: a single-centre experience.

Br J Haematol 2018 03 16;180(6):901-904. Epub 2016 Dec 16.

Division of Hematology/Oncology, Department of Medicine and Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14466DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474218PMC
March 2018

Lymphocytosis, lymphadenopathy: benign or malignant?

Hematology Am Soc Hematol Educ Program 2015 ;2015:106-10

Department of Pathology and the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2015.1.106DOI Listing
October 2016

High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.

J Natl Compr Canc Netw 2016 10;14(10):1274-1281

From Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Biostatistics and Data Coordinating Center, City of Hope National Medical Center, Duarte, California; Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas; Hematology and Stem Cell Transplantation, City of Hope National Medical Center, Duarte, California; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; Departments of Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York; Fox Chase Cancer Center, Philadelphia, Pennsylvania; Medicine/Lymphoma, Memorial Sloan Kettering Cancer Center, New York, New York; and James P. Wilmot Cancer Center, University of Rochester, Rochester, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531178PMC
http://dx.doi.org/10.6004/jnccn.2016.0136DOI Listing
October 2016

Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation.

Leuk Lymphoma 2015 8;56(10):2895-901. Epub 2015 Mar 8.

b Department of Pathology , Northwestern University Feinberg School of Medicine , Chicago , IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1006220DOI Listing
September 2016

Cutaneous Involvement in a Case of Intravascular T-Cell Lymphoma With a γδ Phenotype.

Am J Dermatopathol 2016 Feb;38(2):e27-9

*Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL; and †Division of Hematology-Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DAD.0000000000000383DOI Listing
February 2016

Adverse Events During Hematopoietic Stem Cell Infusion: Analysis of the Infusion Product.

Clin Lymphoma Myeloma Leuk 2015 Nov 2;15(11):e157-62. Epub 2015 Sep 2.

John and Lillian Mathews Center for Cellular Therapy, Northwestern University Feinberg School of Medicine, Chicago, IL; Division of Hematology-Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.08.085DOI Listing
November 2015

Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes.

Leuk Lymphoma 2015 Feb 17;56(2):315-23. Epub 2014 Jun 17.

Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center , Chicago, IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.910654DOI Listing
February 2015

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.

Clin Cancer Res 2014 May 28;20(9):2338-49. Epub 2014 Feb 28.

Authors' Affiliations: Departments of Hematopathology and Biostatistics and Bioinformatics, The University of Texas MD Anderson Cancer Center; The Methodist Hospital, Houston, Texas; Memorial Sloan-Kettering Cancer Center; Weill Medical College of Cornell University; Columbia University Medical Center and New York Presbyterian Hospital, New York, New York; University of North Carolina School of Medicine, Chapel Hill, North Carolina; Cleveland Clinic, Cleveland, Ohio; University of California San Francisco School of Medicine, San Francisco, California; Gundersen Lutheran Health System, La Crosse, Wisconsin; Feinberg School of Medicine, Northwestern University, Chicago, Illinois; San Bartolo Hospital, Vicenza; San Raffaele H. Scientific Institute, Milan, Italy; University Hospital, Basel, Switzerland; Hospital Universitario Marques de Valdecilla, Santander, Spain; Aalborg University Hospital, Aalborg; Odense University Hospital, Odense, Denmark; Medical School of Taizhou University, Taizhou, Zhejiang; University of Hong Kong Li Ka Shing Faculty of Medicine, Hong Kong, China; Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; and Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014309PMC
May 2014

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.

J Clin Oncol 2013 Nov 14;31(33):4199-206. Epub 2013 Oct 14.

Philippe Armand and Edie Weller, Dana-Farber Cancer Institute; David E. Avigan, Beth Israel Deaconess Medical Center; Yi-Bin Chen, Massachusetts General Hospital, Boston, MA; Arnon Nagler, Chaim Sheba Medical Center, Tel-Hashomer; Reuven Or, Hadassah Medical Center, Jerusalem; Rinat Rotem-Yehudar, CureTech, Yavne, Israel; Steven M. Devine, The Ohio State University Comprehensive Cancer Center, Ohio State University, Columbus; Hillard M. Lazarus, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH; Mark S. Kaminski, University of Michigan, Ann Arbor, MI; H. Kent Holland, Northside Hospital; Edmund K. Waller, Winship Cancer Institute, Emory University, Atlanta, GA; Jane N. Winter and Leo I. Gordon, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine; Stephanie A. Gregory, Rush Medical Center, Chicago, IL; James R. Mason, Scripps Clinic; Edward D. Ball, Moores University of California at San Diego Cancer Center, University of California, San Diego; John M. Timmerman and David Andorsky, University of California, Los Angeles, Los Angeles, CA; Joseph W. Fay, Baylor Research Institute, Baylor University Medical Center, Dallas; Chitra M. Hosing, The University of Texas MD Anderson Cancer Center, Houston, TX; David A. Rizzieri, Duke Cancer Center, Durham, NC; Joseph P. Uberti, Karmanos Cancer Institute, Detroit, MI; Markus Y. Mapara, University of Pittsburgh School of Medicine and Cancer Institute, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2012.48.3685
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.48.3685DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878008PMC
November 2013

A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas.

Br J Haematol 2013 Oct 8;163(1):55-61. Epub 2013 Aug 8.

Division of Hematology/Oncology, Tufts University School of Medicine, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12488DOI Listing
October 2013

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma.

N Engl J Med 2013 Oct;369(18):1681-90

From Loyola University Medical Center, Maywood, IL (P.J.S., K.P.B.); Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle (J.M.U., M.L.); Cleveland Clinic, Cleveland (J.R.C., R.R.T.); University of Rochester, Rochester, NY (L.S.C., J.W.F., R.I.F.); Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS (S.C.), University of Calgary-Tom Baker Cancer Centre, Calgary, AB (D.A.S.), and Margaret and Charles Juravinski Cancer Centre, Hamilton, ON (D.M.) - all in Canada; University of North Carolina at Chapel Hill, Chapel Hill (T.C.S.); Ohio State University Medical Center, Columbus (P.P.); Northwestern University, Chicago (J.N.W.); University of Wisconsin, Madison (B.S.K.); University of Arizona, Tucson (T.P.M., L.M.R.); Louisiana State University Health Sciences Center, Shreveport (G.M.M.); City of Hope Medical Center, Duarte, CA (S.J.F.); and Fox Chase Cancer Center-Temple Health, Temple University School of Medicine, Philadelphia (R.I.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1301077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985418PMC
October 2013

Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation.

Leuk Lymphoma 2013 Mar 11;54(3):497-502. Epub 2012 Sep 11.

Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.722215DOI Listing
March 2013

Radioimmunoconjugates in hematopoietic stem cell transplantation.

Cancer Treat Res 2009 ;144:299-315

Division of Medical Oncology, Department of Medicine, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-78580-6_13DOI Listing
September 2010

Radioimmunotherapy for the treatment of non-Hodgkin lymphoma: current status and future applications.

Leuk Lymphoma 2010 Jul;51(7):1163-77

Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428191003793366DOI Listing
July 2010

The novel expanded porphyrin, motexafin gadolinium, combined with [90Y]ibritumomab tiuxetan for relapsed/refractory non-Hodgkin's lymphoma: preclinical findings and results of a phase I trial.

Clin Cancer Res 2009 Oct 13;15(20):6462-71. Epub 2009 Oct 13.

Lymphoma Program, Division of Hematology/Oncology, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, 676 North St. Clair Street, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-0905DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763343PMC
October 2009

ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II.

J Am Coll Radiol 2008 Oct;5(10):1054-66

The Universityof Texas MD Anderson Cancer Center, Department of Radiation Oncology, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacr.2008.06.016DOI Listing
October 2008

Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family.

Br J Haematol 2008 May 15;141(5):676-80. Epub 2008 Apr 15.

Lymphoma Program, Division of Hematology-Oncology, and Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2008.07093.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894542PMC
May 2008

A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma.

Br J Haematol 2008 Feb 19;140(4):385-93. Epub 2007 Dec 19.

Robert H. Lurie Comprehensive Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2007.06908.xDOI Listing
February 2008

Prognostic markers in diffuse large B-cell lymphoma: Keys to the underlying biology.

Authors:
Jane N Winter

Curr Hematol Malig Rep 2007 Oct;2(4):235-41

Division of Hematology-Oncology, Department of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Suite 850, 676 North St. Clair Street, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-007-0032-0DOI Listing
October 2007

Defining the role of immunotherapy and radioimmunotherapy in the treatment of low-grade lymphoma.

Authors:
Jane N Winter

Curr Opin Hematol 2007 Jul;14(4):360-8

Division of Hematology/Oncology and Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e32818a6dafDOI Listing
July 2007

Lack of an association between Chlamydia psittaci and ocular adnexal lymphoma.

Leuk Lymphoma 2007 Mar;48(3):577-83

Department of Ophthalmology, Northwestern University Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190601132105DOI Listing
March 2007

Radioimmunotherapeutic strategies in autologous hematopoietic stem-cell transplantation for malignant lymphoma.

Best Pract Res Clin Haematol 2006 ;19(4):669-84

Mayo Clinic College of Medicine, Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2006.05.004DOI Listing
December 2006

Current controversies in follicular lymphoma.

Blood Rev 2006 Jul 10;20(4):179-200. Epub 2006 Jan 10.

Division of Hematology & Oncology, Department of Medicine, Northwestern University, Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, 676 N. St. Clair Street, Suite 850, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2005.11.003DOI Listing
July 2006

Follicular lymphoma: today's treatments and tomorrow's targets.

Expert Opin Pharmacother 2006 Jul;7(10):1273-90

Northwestern University Feinberg School of Medicine, Division of Hematology & Oncology, Department of Medicine and the Robert H. Lurie Comprehensive Cancer Center, 676 N. St. Clair Street, Suite 850, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.7.10.1273DOI Listing
July 2006

Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug.

Expert Opin Biol Ther 2006 Apr;6(4):409-15

Feinberg School of Medicine, Division of Hematology/Oncology, Department of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 676 N. St. Clair St., Suite 850, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.6.4.409DOI Listing
April 2006

Classical Hodgkin's lymphoma presenting with tongue involvement: a case report and review of the literature.

Clin Lymphoma Myeloma 2006 Mar;6(5):410-3

Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2006.n.020DOI Listing
March 2006

Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomas.

Haematologica 2006 Jan;91(1):114-20

Division of Hematology/Oncology, Department of Medicine, The Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
January 2006